Last reviewed · How we verify
combination of sumatriptan and naproxen — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
combination of sumatriptan and naproxen (combination of sumatriptan and naproxen) — IRCCS San Raffaele Roma.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| combination of sumatriptan and naproxen TARGET | combination of sumatriptan and naproxen | IRCCS San Raffaele Roma | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- combination of sumatriptan and naproxen CI watch — RSS
- combination of sumatriptan and naproxen CI watch — Atom
- combination of sumatriptan and naproxen CI watch — JSON
- combination of sumatriptan and naproxen alone — RSS
Cite this brief
Drug Landscape (2026). combination of sumatriptan and naproxen — Competitive Intelligence Brief. https://druglandscape.com/ci/combination-of-sumatriptan-and-naproxen. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab